INTEGRATIVE APPROACH TO THE DIAGNOSIS AND TREATMENT OF VULVAR CANCER

Authors

  • Navruzova Visola Sarimbekovna Doctor of Medical Sciences, Associate Professor Author
  • Usmonjonova Dilnozakhon Hayotjon qizi Author
  • Mamasharipova Shohidakhon Bakhtiyorjon qizi Author

DOI:

https://doi.org/10.5281/zenodo.20344029

Keywords:

vulvar cancer, integrative oncology, gynecologic oncology, molecular diagnostics, immunotherapy, radiotherapy, multidisciplinary treatment.

Abstract

Vulvar cancer is a rare gynecologic malignancy associated with significant physical and psychological complications. This article evaluates modern integrative approaches to the diagnosis and treatment of vulvar cancer. The study was based on analysis of scientific literature, clinical guidelines, and peer-reviewed oncology research. The findings demonstrated that multidisciplinary management improves early diagnosis, accurate staging, individualized treatment planning, and postoperative rehabilitation. Advanced imaging, molecular diagnostics, organ-preserving surgery, sentinel lymph node biopsy, radiotherapy, immunotherapy, and psychosocial support contribute to better oncologic and functional outcomes. Integrative oncology enhances patient quality of life and supports personalized treatment strategies.

 

References

1.Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. International Journal of Gynecology and Obstetrics. 2015;131:S76–S83.

2.Woelber L, Mahner S, Voelker K, et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Research. 2019;39(10):5453–5460.

3.Te Grootenhuis NC, van der Zee AGJ, van Doorn HC, et al. Sentinel nodes in vulvar cancer: long-term follow-up of the GROINSS-V studies. Journal of Clinical Oncology. 2016;34(15):1829–1837.

4.Rogers LJ, Cuello MA. Cancer of the vulva. International Journal of Gynecology and Obstetrics. 2018;143(S2):4–13.

5.Nooij LS, Brand FA, Gaarenstroom KN, et al. Risk factors and treatment for recurrent vulvar squamous cell carcinoma. Critical Reviews in Oncology/Hematology. 2016;106:1–13.

6.Ansink A, van der Velden J. Surgical interventions for early squamous cell carcinoma of the vulva. Cochrane Database of Systematic Reviews. 2017.

7.Gadducci A, Tana R, Barsotti C, Guerrieri ME, Genazzani AR. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. Critical Reviews in Oncology/Hematology. 2012;83(1):71–83.

8.Oonk MHM, Planchamp F, Baldwin P, et al. European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer. International Journal of Gynecological Cancer. 2017;27(4):832–837.

9.Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics. CA: A Cancer Journal for Clinicians. 2021;71(3):209–249.

10.Fons G, Groenen SM, Oonk MHM, et al. Adjuvant radiotherapy in vulvar cancer. Gynecologic Oncology. 2020;157(2):420–427.

Downloads

Published

2026-05-22